清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Sentinel lymph node biopsy versus lymphadenectomy in early-stage cervical cancer: a meta-analysis of oncologic outcomes and surgical morbidity

作者
Chao Xiao,Siyuan Zeng,Luying Li,Ruiqi L. Wang,Xue Xiao
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:16: 1765529-1765529
标识
DOI:10.3389/fonc.2026.1765529
摘要

Objective: This study aimed to evaluate the oncologic safety of sentinel lymph node biopsy (SLNB) compared with systematic lymph node dissection (LND) in patients with early-stage cervical cancer and to determine whether SLNB alone yields comparable survival outcomes. Data sources: Studies published up to October 2025 were systematically searched in PubMed, Embase, and Web of Science using relevant keywords, including "sentinel lymph node", "cervical cancer", "cervical carcinoma" and "lymphadenectomy." Study eligibility criteria: Comparative cohort studies and single-arm studies involving patients with early-stage cervical cancer undergoing SLNB, with or without LND, and reporting survival outcomes- including cancer-specific survival (CSS), disease-specific survival (DSS), overall survival (OS), progression-free survival (PFS), and disease-free survival (DFS) -were included. Study appraisal and synthesis methods: The quality of the included studies was assessed using appropriate tools: the Cochrane Risk of Bias 2.0 (RoB 2) tool for randomized controlled trials, the Newcastle-Ottawa Scale (NOS) for observational studies, and the Methodological Index for Non-Randomized Studies (MINORS) for single-arm or non-randomized studies. All meta-analyses were performed using the meta package in R. Hazard ratios (HRs) and risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using fixed- or random-effects models depending on heterogeneity. Sensitivity analyses were conducted via leave-one-out analysis. Results: The pooled analysis of six comparative studies revealed no significant difference in cancer-specific survival (HR = 0.93, 95% CI: 0.27-3.20), overall survival (HR = 0.92 (95% CI: 0.65-1.31), disease-free survival (HR = 0.99, 95%CI: 0.00-855.48), or progression-free survival (HR = 0.71, 95% CI: 0.29-1.05) between the SLNB and LND groups. SLNB was associated with a significantly lower risk of postoperative complications (RR = 0.70, P = 0.0406), and did not increase the recurrence rate (RR = 0.96, 95% CI: 0.36-2.53) compared with LND. Six single-arm studies reported 5-year OS and DFS rates of 97% and 94%, respectively, following SLNB alone. The pooled SLNB positivity rate across 13 studies was 8% (95% CI: 5%-12%). Sensitivity analysis confirmed the robustness of the CSS results. Conclusion: This study suggests that SLNB provides oncologic outcomes comparable to LND while reducing surgical morbidity in early-stage cervical cancer. The inclusion of CSS as a validated endpoint reinforces the cancer-specific safety of SLNB, with no significant compromise observed in either OS or PFS. While current evidence is promising, further large-scale prospective trials are needed to refine indications and standardize implementation of SLNB in routine clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Maestro_S的应助被博修采纳,获得100
1秒前
魔幻荧完成签到,获得积分10
1秒前
张博完成签到 ,获得积分10
2秒前
LYH完成签到,获得积分10
8秒前
J_Xu完成签到 ,获得积分10
9秒前
七叶花开完成签到,获得积分10
9秒前
SunJay完成签到 ,获得积分10
10秒前
复杂以旋完成签到,获得积分10
18秒前
心无杂念完成签到 ,获得积分10
19秒前
Shicheng发布了新的文献求助10
20秒前
忧虑的静柏完成签到 ,获得积分10
23秒前
果酱完成签到,获得积分10
28秒前
科研通AI6.3的应助被leapper采纳,获得10
33秒前
如意2023完成签到 ,获得积分10
36秒前
阿晖完成签到,获得积分10
37秒前
鲜艳的念寒完成签到,获得积分10
37秒前
领导范儿的应助被菲菲采纳,获得10
41秒前
Zoe完成签到,获得积分0
47秒前
48秒前
彩色的可冥完成签到,获得积分10
48秒前
奔跑的应助被cc采纳,获得10
49秒前
程志强完成签到 ,获得积分10
49秒前
樂楽完成签到,获得积分10
51秒前
小孟小孟完成签到 ,获得积分10
55秒前
噜噜晓完成签到 ,获得积分10
1分钟前
xiepeijuan的应助被lili采纳,获得10
1分钟前
1分钟前
免疫小白完成签到 ,获得积分10
1分钟前
leapper发布了新的文献求助10
1分钟前
绵绵冰完成签到 ,获得积分10
1分钟前
1分钟前
开放的花卷完成签到 ,获得积分10
1分钟前
菲菲发布了新的文献求助10
1分钟前
龙行天下完成签到 ,获得积分10
1分钟前
大大完成签到 ,获得积分10
1分钟前
狞风妖完成签到 ,获得积分10
1分钟前
菲菲完成签到,获得积分10
1分钟前
悄然飘去完成签到 ,获得积分10
1分钟前
复杂妙海完成签到,获得积分10
1分钟前
轩辕十四完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173230
求助须知:如何正确求助?哪些是违规求助? 9565593
关于积分的说明 21780536
捐赠科研通 7767429
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555764
邀请新用户注册赠送积分活动 2476697